Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
AstraZeneca
Dow
Mallinckrodt
Johnson and Johnson

Last Updated: August 17, 2022

Drugs in MeSH Category Anti-Bacterial Agents


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065505-002 Jul 31, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Torrent MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET;ORAL 065156-002 Jan 6, 2004 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
B Braun CEFTAZIDIME IN DEXTROSE CONTAINER ceftazidime INJECTABLE;INJECTION 050823-002 Jun 13, 2011 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Eugia Pharma AZITHROMYCIN azithromycin INJECTABLE;INJECTION 203294-001 Jun 19, 2015 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Ani Pharms ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate GRANULE;ORAL 062055-001 Approved Prior to Jan 1, 1982 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Wyeth Ayerst UNIPEN nafcillin sodium FOR SOLUTION;ORAL 050199-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Delcor Asset Corp MYCOSTATIN nystatin PASTILLE;ORAL 050619-001 Apr 9, 1987 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.